PMID: 29 NakamuraTConradM
The peptide's demonstrated safety in gastric juice stability and lack of toxic effects across wide dose ranges support its potential for gastrointestinal therapeutic applications pending further clinical validation
Glutathione-linking cell proliferation to oxidative stress
Batch-Specific Certificates of Analysis (CoA): Each batch should come with a CoA detailing all tests performed
The TGA reports a number of adverse events and other concerns received for unapproved peptide products, which include: severe allergic reactions, requiring doses of adrenaline and hospitalisation systemic inflammatory response syndrome (SIRS) (severe inflammation in the body), requiring hospital management generalised hypersensitivity symptoms such as fullbody intense itching, palpitations, pain and sweating wide ranging body side effects, including insomnia, blurred vision, extreme tiredness, flulike illness, joint pain and skin sensitivity musculoskeletal injuries, including plantar fasciitis and Achilles tendinitis, and poor product quality, including unsealed packaging from an online supplier